Learn how AI is changing the way life science brands and research centers approach drug discovery, and how technology could help save millions of lives.

Netguru is a digital consultancy and software development company that shares insights, case studies, and best practices on building digital products, scaling engineering teams, and driving innovation in technology. Through its blog, Netguru covers topics such as product design, agile methodologies, DevOps practices, and emerging technologies like artificial intelligence and blockchain. Developers and business leaders can learn from Netguru's expertise in delivering high-quality software solutions and navigating the ever-changing landscape of digital transformation.

Netguru

AI-powered target identification in drug discovery has the potential to accelerate and improve the process of identifying new drug targets. AI algorithms can sift through vast databases of molecular structures and predict effective compounds. However, there are limitations to AI in drug discovery, as some AI-generated molecules have not successfully transitioned to clinical development. Examples of AI-powered target identification include the University of Cambridge's identification of new targets for human disease and companies like Atomwise and Deep Genomics using AI for drug discovery.

Faster Drug Discovery? Meet AI-Powered Target Identification

AI drug discovery limitations – what to watch out for

Examples of AI-powered target identification

AI-powered drug discovery isn’t going away